Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
about
Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial.Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.The Otology Questionnaire Amsterdam: a generic patient reported outcome measure about the severity and impact of ear complaints. A cross-sectional study on the development of this questionnaire.Translabyrinthine vestibular neurectomy and simultaneous cochlear implant for Ménière's disease.
P2860
Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
@en
Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
@nl
type
label
Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
@en
Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
@nl
prefLabel
Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
@en
Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
@nl
P1433
P1476
Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.
@en
P2093
Aimee M Verrall
George A Gates
P304
P356
10.1001/ARCHOTOL.131.10.863
P577
2005-10-01T00:00:00Z